Indeed, the inhibition of fatty acid β-oxidation by etomoxir proved to be an effective strategy to overcome hypoxia-mediated resistance to radiotherapy in cancer cells,103 suggesting an important role for ETF:QO in cancer survival under hypoxia. This evidence concerns the gene TEAD2 and cancer.